Our analyses are primarily descriptive and correlative, focusing on the quantification of TIM-3 and Gal-9 protein levels and their associations with common oncogenic mutations and selected immunological parameters in CRC tissues. The gene discussed is HAVCR2; the disease is colorectal carcinoma.